News for Verrica Pharmaceuticals Inc Stock (VRCA)

Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm

Newsfile Corp • 09/08/20

MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp • 09/08/20

VRCA Class Action Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

Newsfile Corp • 08/25/20

Verrica Pharmaceuticals Licenses LTX-315, A First-in-Class Oncolytic Peptide Based Immunotherapy, from Lytix Biopharma AS, for the Treatment of Dermatologic Oncology Indications

GlobeNewsWire • 08/11/20

Verrica Pharmaceuticals Reports Second Quarter 2020 Financial Results

GlobeNewsWire • 08/05/20

Verrica Pharmaceuticals: The Fundamentals Aren't So Clear, But The Stock Chart May Be Telling Us Something

Seeking Alpha • 07/30/20

VRCA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

Newsfile Corp • 07/24/20

Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors

GlobeNewsWire • 07/23/20

Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes

GlobeNewsWire • 07/23/20

VRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

Newsfile Corp • 07/22/20

Verrica Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm

Newsfile Corp • 07/20/20

Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Verrica Pharmaceuticals, Inc. – VRCA

Business Wire • 07/17/20

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile Corp • 07/17/20

Shareholder Alert: Robbins LLP Announces Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders

Business Wire • 07/16/20

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire • 07/16/20

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire • 07/16/20

VRCA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

Newsfile Corp • 07/15/20

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc.

Business Wire • 07/15/20

VERRICA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc.

Business Wire • 07/14/20

The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.

Business Wire • 07/14/20

Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

GlobeNewsWire • 07/14/20

Verrica (VRCA) in Focus: Stock Moves 8.9% Higher

Zacks Investment Research • 07/13/20

The Law Offices of Frank R. Cruz Continues Its Investigation of Verrica Pharmaceuticals Inc.

Business Wire • 07/09/20

Shareholder Alert: Robbins LLP Announces It Is Investigating the Officers and Directors of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Shareholders

Business Wire • 07/06/20

VRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

PRNewsWire • 07/02/20